GPCRs-Targeted Drug Discovery Summit Leaderboard
  • Sunday, May 3, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

Obesity & Weight Loss Drug Development Summit Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 832

Author

Pharma Journalist 8769 posts 0 comments

FDA authorizes Flourish Pediatric Esophageal Atresia Anastomosis to treat esophageal atresia

May 15, 2017
FDA announced the authorization of Flourish Pediatric Esophageal Atresia Anastomosis to treat esophageal atresia in Infants. Flourish Pediatric Esophageal Atresia Anastomosis is a…
Read More...

Norgine and Merus Labs Enter into a Merger Agreement

May 11, 2017
Norgine B.V. and Merus Labs International announced that they have entered into a merger agreement under which Norgine will acquire all of the issued and outstanding common shares of…
Read More...

FDA authorizes for the NANT Cancer Vaccine Clinical Trial

May 11, 2017
NantCell and NantKwest announced that the FDA has authorized NANT Cancer Vaccine for clinical trial enrollment (ClinicalTrials.gov NCT03136406). The NANT Cancer Vaccine is the first…
Read More...

Dr. Sandeep Reddy appointed as CMO of NantHealth

May 11, 2017
NantHealth announced that Dr. Sandeep Reddy has been appointed as Chief Medical Officer. He will be responsible for overseeing education, outreach, clinical development programs, and…
Read More...

Novocure elects Martin J. Madden to Board of Directors

May 11, 2017
Novocure announced that it has elected Martin J. Madden to its Board of Directors in the meeting of shareholders. Mr. Madden recently retired after a 30-year career in medical device…
Read More...

Avita Medical filed IPR petition against Patent owned by Renovacare Sciences

May 11, 2017
Avita Medical Limited filed an IPR (Inter Partes Review) petition against US Patent No. 9,610,430 owned by Renovacare Sciences and request that all claim in the patent should be…
Read More...

Lensar and PDL announces completion of LENSAR’s financial restructuring

May 11, 2017
LENSAR and PDL BioPharma announced the completion of LENSAR's financial restructuring with a court-approved exit plan finalized on May 11, 2017.   As part of the plan, PDL will convert…
Read More...

Catalent to commercially Manufacture Lexicon XERMELO following FDA Approval

May 11, 2017
Catalent Pharma Solutions announced that it will commercially manufacture Lexicon Pharmaceuticals, XERMELO following the FDA  approval at its Kansas City facility. XERMELO…
Read More...

INC Research and inVentiv Health approves merge agreement

May 11, 2017
INC Research and inVentiv Health announced that their Boards of Directors have  approved a definitive merger agreement pursuant to which their businesses would combine in an all-stock…
Read More...

FDA awards Proteon Therapeutics Breakthrough Therapy Designation

May 11, 2017
Proteon Therapeutics announced that FDA has awarded Breakthrough Therapy Designation to vonapanitase (investigational treatment) for increasing arteriovenous fistula secondary patency…
Read More...
Prev Next
Neuropsychiatric Drug Development Summit
International Neoantigen Summit
Lab Ops & Facility Management for Biopharma West Summit
10th IPF Summit
Medical Device Software Development Summit
Liquid Biopsy for Precision Oncology Summit East Coast
ADC Linker & Conjugation Summit
GPCRs-Targeted Drug Discovery Summit
5th World ADC Summit South Korea
Extrahepatic Lipid-Based Nanoparticles Delivery Summit
World TPD & Induced Proximity Summit South Korea
Measuring Patient Engagement Summit
Investigative & Preclinical Toxicology Summit 2026
LEAP HR: Life Sciences West
Oligonucleotides for CNS Summit
R&D Procurement & Sourcing in Pharma Summit
In Vivo Cell Engineering & Gene Editing Summit
PFS & Injectable Drug Delivery West Coast
Obesity & Weight Loss Drug Development Summit
T-Cell Engager Therapeutics Summit
mRNA-Based Therapeutics Summit
World Bispecific & T-Cell Engager Summit South Korea
TCR-Based Therapies Summit
PFS & Injectable Drug Devices East Coast
5th ADC Analytical Development Summit
Nasal Formulation & Delivery Summit
Peptide-Based Therapeutics Summit 2026
ALS Drug Development Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • Gilead Completes $7.8 Billion Arcellx Acquisition Deal
  • EU Approves Rhapsido for Chronic Hives Treatment
  • Lilly to Acquire Ajax in $2.3 Billion Deal
  • Saphnelo Pen Approval Expands Lupus Treatment Access
  • BioMarin Completes $4.8 Billion Amicus Acquisition

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Regeneron Goes All In on Radiopharma with $2.1B Telix Deal…

IQ MPS Leaders to Share Industry Progress on Advancing In…

4th ADC Linker & Conjugation Summit Announces 2026…

Turning Biophysical Data into Confident Drug Discovery…

Targeted LNP Delivery Beyond the Liver: The Challenges…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.